ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS Article

Fisher, Barbara, Zhang, Peixin, Macdonald, David et al. (2018). ACTR-02. NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 20(suppl_6), vi11-vi11. 10.1093/neuonc/noy148.039

cited authors

  • Fisher, Barbara; Zhang, Peixin; Macdonald, David; Chakravarti, Arnab; Lesser, Glenn; Fox, Sherry; Coons, Stephen; Rogers, Leland; Werner-Wasik, Maria; Doyle, Thomas; Bahary, Jean-Paul; Fiveash, John; Bovi, Joseph; Howard, Steven; Yu, Michael; Dsouza, David; Laack, Nadia; Roach, Mack; Kwok, Young; Wahl, Daniel; Stasser, John; Won, Minhee; Mehta, Minesh P

authors

publication date

  • November 5, 2018

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6 Evaluation of treatments and therapeutic interventions
  • 6.5 Radiotherapy and other non-invasive therapies
  • Brain Cancer
  • Brain Disorders
  • Cancer
  • Clinical Research
  • Rare Diseases

Digital Object Identifier (DOI)

publisher

  • Oxford University Press (OUP)

start page

  • vi11

end page

  • vi11

volume

  • 20

issue

  • suppl_6